These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8785971)

  • 1. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying and purifying protective immunogens from cultures of Clostridium chauvoei.
    Hauer PJ; Rosenbusch RF
    Dev Biol Stand; 1996; 86():332. PubMed ID: 8785972
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens.
    Crichton R; Solomon J; Barton AM
    Biologicals; 1990 Jan; 18(1):49-54. PubMed ID: 2317354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 7. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and identification in Senegal of the most immunogenic protein soluble antigen of a Clostridium chauvoei strain].
    Mbengue MB
    Bull Soc Pathol Exot; 2008 Feb; 101(1):3-4. PubMed ID: 18431995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of rocket immuno-electrophoresis (RIE) and ELISA for determination of tetanus antibodies in tetanus immunoglobulins.
    Zott A
    Dev Biol Stand; 1996; 86():348. PubMed ID: 8785988
    [No Abstract]   [Full Text] [Related]  

  • 11. Some observations on the quality control testing of Clostridium chauvoei vaccines.
    Chandler HM
    Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an in vitro assay for measuring the relative potency of leptospiral bacterins containing serovar canicola and its correlation to the hamster potency assay.
    Ruby KW; Walden DM; Wannemuehler MJ
    Dev Biol Stand; 1996; 86():341. PubMed ID: 8785981
    [No Abstract]   [Full Text] [Related]  

  • 13. Some problems concerning the assay of Clostridium chauvoei vaccine in laboratory animals.
    Knight PA; Kent J
    Dev Biol Stand; 1976; 32():143-50. PubMed ID: 1001828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
    Henderson LM; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects for the refinement and reduction of animal usage in the potency testing of Cl. chauvoei vaccines.
    Tilleray JH; Knight PA
    Dev Biol Stand; 1986; 64():111-8. PubMed ID: 3792641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of ELISA to quantify the antitoxin content of commercial equine tetanus antitoxin.
    Kolbe DR
    Dev Biol Stand; 1996; 86():336. PubMed ID: 8785976
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the Leptospira pomona ELISA and its correlation with the hamster potency assay.
    Ruby KW
    Dev Biol Stand; 1996; 86():340. PubMed ID: 8785980
    [No Abstract]   [Full Text] [Related]  

  • 19. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective cellular antigen of Clostridium chauvoei.
    Stevenson JR; Stonger KA
    Am J Vet Res; 1980 Apr; 41(4):650-3. PubMed ID: 7406286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.